-
Crisaborole
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Crisaborole Dermatitis Atopic me te Eczema Pfizer -
Etelcacetide
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Etelcacetide Hiperparathyroidism tuarua (HPT) Amgen -
Abemaciclib
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Abemaciclib Te mate pukupuku uma, te maimoatanga mate pukupuku prostate Eri Rengarenga Tihema 15,2029 -
Deucracitinib
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Deucracitinib Anti tohu psoriasis Kamupene Bristol-Myers Squibb Noema 07,2033 -
Apemilast
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Apemilast mate pukupuku psoriatic Celgene -
Remdesivir
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Remdesivir Antivirul(Ebola, Covid-19) Ko Kireara -
Paxlovid
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Paxlovid Covid-19 Pfizer -
Pomalidomide
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Pomalidomide Te rongoa oncology Celgene -
Nirmatrelvir
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Nirmatrelvir 3C-Like Protease (3CLPRO) Inhibitor Me SARS-Cov-2 Mpro Inhibitor -
Eltrombopag
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Eltrombopag ITP & Aplastic anemia Novartis & GSK Mei. 20, 2023 -
Ruxolitinib
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Ruxolitinib Myelofibrosis Novartis Hūrae 6, 2024 -
Crisaborole
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Crisaborole Dermatitis Atopic me te Eczema Pfizer Hune 11, 2026